A benign tumor composed, wholly or in part, of cells with the morphologic characteristics of HISTIOCYTES and with various fibroblastic components. Fibrous histiocytomas can occur anywhere in the body. When they occur in the skin, they are called dermatofibromas or sclerosing hemangiomas. (From DeVita Jr et al., Cancer: Principles & Practice of Oncology, 5th ed, p1747)
The most commonly diagnosed soft tissue sarcoma. It is a neoplasm with a fibrohistiocytic appearance found chiefly in later adult life, with peak incidence in the 7th decade.
A neoplasm containing HISTIOCYTES. Important forms include BENIGN FIBROUS HISTIOCYTOMA; and MALIGNANT FIBROUS HISTIOCYTOMA.
Neoplasms of whatever cell type or origin, occurring in the extraskeletal connective tissue framework of the body including the organs of locomotion and their various component structures, such as nerves, blood vessels, lymphatics, etc.
Malignant neoplasms composed of MACROPHAGES or DENDRITIC CELLS. Most histiocytic sarcomas present as localized tumor masses without a leukemic phase. Though the biological behavior of these neoplasms resemble lymphomas, their cell lineage is histiocytic not lymphoid.
A connective tissue neoplasm formed by proliferation of mesodermal cells; it is usually highly malignant.
Neoplasms of the bony part of the skull.
A malignant tumor derived from primitive or embryonal lipoblastic cells. It may be composed of well-differentiated fat cells or may be dedifferentiated: myxoid (LIPOSARCOMA, MYXOID), round-celled, or pleomorphic, usually in association with a rich network of capillaries. Recurrences are common and dedifferentiated liposarcomas metastasize to the lungs or serosal surfaces. (From Dorland, 27th ed; Stedman, 25th ed)
Retroperitoneal neoplasms are a diverse group of tumors that originate in the retroperitoneal space, which is the area behind the peritoneum and includes the kidneys, adrenal glands, pancreas, and major blood vessels.
Femoral neoplasms refer to abnormal growths or tumors, benign or malignant, located in the femur bone or its surrounding soft tissues within the thigh region.
A condition with multiple tumor-like lesions caused either by congenital or developmental malformations of BLOOD VESSELS, or reactive vascular proliferations, such as in bacillary angiomatosis. Angiomatosis is considered non-neoplastic.
A sarcoma, usually a liposarcoma or malignant fibrous histiocytoma, with an abundant component of myxoid tissue resembling primitive mesenchyme containing connective tissue mucin. (Stedman, 25th ed)
The use of HIGH-ENERGY SHOCK WAVES, in the frequency range of 20-30 kHz, to cut through mineralized tissue.
Neoplasms located in the vasculature system, such as ARTERIES and VEINS. They are differentiated from neoplasms of vascular tissue (NEOPLASMS, VASCULAR TISSUE), such as ANGIOFIBROMA or HEMANGIOMA.
Tumors in any part of the heart. They include primary cardiac tumors and metastatic tumors to the heart. Their interference with normal cardiac functions can cause a wide variety of symptoms including HEART FAILURE; CARDIAC ARRHYTHMIAS; or EMBOLISM.
Tumors or cancer located in bone tissue or specific BONES.
Tumor or cancer of the MALE GENITALIA.
A rare and probably congenital condition characterized by great enlargement of the lumen of the trachea and the larger bronchi.
Death resulting from the presence of a disease in an individual, as shown by a single case report or a limited number of patients. This should be differentiated from DEATH, the physiological cessation of life and from MORTALITY, an epidemiological or statistical concept.
Diseases of the domestic dog (Canis familiaris). This term does not include diseases of wild dogs, WOLVES; FOXES; and other Canidae for which the heading CARNIVORA is used.
Disappearance of a neoplasm or neoplastic state without the intervention of therapy.
The portion of the leg in humans and other animals found between the HIP and KNEE.
Tumors of bone tissue or synovial or other soft tissue characterized by the presence of giant cells. The most common are giant cell tumor of tendon sheath and GIANT CELL TUMOR OF BONE.
A benign tumor of fibrous or fully developed connective tissue.
Macrophages found in the TISSUES, as opposed to those found in the blood (MONOCYTES) or serous cavities (SEROUS MEMBRANE).
Tumors or cancer of the MAXILLARY SINUS. They represent the majority of paranasal neoplasms.
Histochemical localization of immunoreactive substances using labeled antibodies as reagents.
Neoplasms of the bony orbit and contents except the eyeball.
Tumors or cancer of the SKIN.
A sarcoma of the deep layers of the skin. The tumors are locally aggressive tends to recur but rarely metastatic. It can be classified into variants depending on the cell type tumors are derived from or by its characteristics: Pigmented variant from MELANIN-containing DERMAL DENDRITIC CELLS; Myxoid variant, myxoid STROMAL CELLS; Giant cell variant characterized by GIANT CELLS in the tumors; and Fibrosarcomatous variant chracterized by tumor areas histologically indistinguishable from FIBROSARCOMA.
Tomography using x-ray transmission and a computer algorithm to reconstruct the image.
A sarcoma originating in bone-forming cells, affecting the ends of long bones. It is the most common and most malignant of sarcomas of the bones, and occurs chiefly among 10- to 25-year-old youths. (From Stedman, 25th ed)
A malignant neoplasm derived from glandular epithelium, in which cystic accumulations of retained secretions are formed. The neoplastic cells manifest varying degrees of anaplasia and invasiveness, and local extension and metastases occur. Cystadenocarcinomas develop frequently in the ovaries, where pseudomucinous and serous types are recognized. (Stedman, 25th ed)
A sarcoma containing large spindle cells of smooth muscle. Although it rarely occurs in soft tissue, it is common in the viscera. It is the most common soft tissue sarcoma of the gastrointestinal tract and uterus. The median age of patients is 60 years. (From Dorland, 27th ed; Holland et al., Cancer Medicine, 3d ed, p1865)
Two or more abnormal growths of tissue occurring simultaneously and presumed to be of separate origin. The neoplasms may be histologically the same or different, and may be found in the same or different sites.
A slowly growing malignant neoplasm derived from cartilage cells, occurring most frequently in pelvic bones or near the ends of long bones, in middle-aged and old people. Most chondrosarcomas arise de novo, but some may develop in a preexisting benign cartilaginous lesion or in patients with ENCHONDROMATOSIS. (Stedman, 25th ed)
Tumors or cancer of the MEDIASTINUM.

Diaphyseal medullary stenosis with malignant fibrous histiocytoma: a hereditary bone dysplasia/cancer syndrome maps to 9p21-22. (1/307)

Diaphyseal medullary stenosis with malignant fibrous histiocytoma (DMS-MFH) is an autosomal dominant bone dysplasia/cancer syndrome of unknown etiology. This rare hereditary cancer syndrome is characterized by bone infarctions, cortical growth abnormalities, pathological fractures, and eventual painful debilitation. Notably, 35% of individuals with DMS develop MFH, a highly malignant bone sarcoma. A genome scan for the DMS-MFH gene locus in three unrelated families with DMS-MFH linked the syndrome to a region of approximately 3 cM on chromosome 9p21-22, with a maximal two-point LOD score of 5.49 (marker D9S171 at recombination fraction [theta].05). Interestingly, this region had previously been shown to be the site of chromosomal abnormalities in several other malignancies and contains a number of genes whose protein products are involved in growth regulation. Identification of this rare familial sarcoma-causing gene would be expected to simultaneously define the cause of the more common nonfamilial, or sporadic, form of MFH-a tumor that constitutes approximately 6% of all bone cancers and is the most frequently occurring adult soft-tissue sarcoma.  (+info)

Color Doppler sonography of focal lesions of the skin and subcutaneous tissue. (2/307)

We evaluated with color Doppler sonography 71 visible and palpable nodules of the skin and subcutaneous tissue from 51 patients. The nodules were classified as avascular (type I), hypovascular with a single vascular pole (type II), hypervascular with multiple peripheral poles (type III), and hypervascular with internal vessels (type IV). Of the 32 malignant nodules, 9% showed a type I pattern, 50% had a type III pattern, and 41% had a type IV pattern; of the 39 benign nodules, 86% showed a type I pattern and 14% had a type II pattern. The sensitivity and specificity of hypervascularity in malignant lesions were 90% and 100%, respectively, whereas the sensitivity and specificity of hypovascularity in benign lesions were 100% and 90%, respectively. The authors conclude that color Doppler sonography is able to increase the specificity of ultrasonography in the evaluation of nodular lesions of the skin.  (+info)

Pathologic odontoid fracture and benign fibrous histiocytoma of bone. (3/307)

We present the case of a 44-year-old female patient, who sustained an odontoid fracture after a minor trauma (uncomplicated fall). The radiologic evaluation revealed a skeletal tumor of the second cervical vertebra together with a fracture line at the base of the odontoid process of the axis. The patient underwent surgery, the tumor was resected and the odontoid was stabilised using an autologous cortico-cancellous bone graft and a halo fixator. Histologic examination revealed benign fibrous histiocytoma, which is reported to be a very rare skeletal tumor.  (+info)

Identification and characterization of a novel UDP-GalNAc:GlcAbeta-R alpha1,4-N-acetylgalactosaminyltransferase from a human sarcoma cell line. (4/307)

We recently discovered a novel alpha-N-acetylgalactosaminyltransferase in fetal bovine serum (Kitagawa et al., J. Biol. Chem., 270, 22190-22195, 1995) and also in mouse mast cytoma cells (Lidholt et al., Glycoconjugate J., 14, 737-742, 1997), which catalyzed the transfer of an alpha-GalNAc residue to the linkage tetrasaccharide-serine, GlcAbeta1-3Galbeta1-3Galbeta1-4Xylbeta1-O-Ser, derived from proteoglycans. In this study, we characterized this enzyme using a preparation obtained from the serum-free culture medium of a human sarcoma (malignant fibrous histiocytoma) cell line by phenyl-Sepharose chromatography. Structural characterization by1H NMR spectroscopy of the reaction product using the linkage tetrasaccharide-serine, GlcAbeta1-3Galbeta1-3Galbeta1-4Xylbeta1-O-Ser, as a substrate demonstrated that the enzyme was a UDP-GalNAc:GlcAbeta1-R alpha1,4-N -acetylgalactosaminyltransferase. This is the first identification of an alpha1,4-N-acetylgalactosaminyltransferase. Using N -acetylchondrosine GlcAbeta1-3GalNAc as an alternative substrate, the enzyme required divalent cations for the transferase reaction, with maximal activity at 20 mM Mn2+and exhibited a dual optimum at pH 6.5 and pH 7.4 depending upon the buffers used, with the highest activity in a 50 mM 2-( N -morpholino)ethanesulfonic acid buffer at pH 6.5. The apparent Km values obtained for N -acetylchondrosine, the linkage tetrasaccharide-serine, and UDP-GalNAc were 1060 microM, 188 microM, and 27 microM, respectively. This suggested that the linkage tetrasaccharide-serine was a good acceptor substrate for the enzyme. In addition, the enzyme utilized glucuronylneolactotetraosylceramide GlcAbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4G lcbeta1-1Cer but not sulfoglucuronylneolactotetraosylceramide GlcA(3-O -sulfate)beta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Gl cbeta1-1Cer as acceptor substrates. The possibility of involvement of this enzyme in the biosynthesis of glycosaminoglycan as well as other GlcA-containing glycoconjugates is discussed.  (+info)

Doxorubicin-cisplatin chemotherapy for high-grade nonosteogenic sarcoma of bone. Comparison of treatment and control groups. (5/307)

OBJECTIVE: To evaluate the role of chemotherapy with a combination of doxorubicin (adriamycin) and cisplatin in high-grade, nonosteogenic, non-Ewing's sarcoma (non-OSA) of bone. DESIGN: A case series comparison with a literature-derived control group. SETTING: A university-affiliated tertiary care centre. PATIENTS: Thirty patients with a diagnosis of non-OSA. Of these, 8 had low-grade disease (grade 1 or 2) and 22 had high-grade disease (grade 3). Eleven of the 22 with high-grade disease had malignant fibrous histiocytoma. Seventeen patients with nonmetastatic high-grade non-OSA were compared with a literature cohort of 37 patients who met the eligibility criteria of nonmetastatic, high-grade non-OSA treated with surgery, with or without radiotherapy. The mean follow-up was 25.2 months. INTERVENTIONS: Eight patients with low-grade tumour underwent surgery alone; 22 patients with high-grade tumour underwent surgery and 6 courses of adriamycin (75 mg/m2 every 3 weeks) and cisplatin (100 mg/m2 every 3 weeks). MAIN OUTCOME MEASURES: Disease-free survival and overall survival in those with high-grade tumours treated with or without chemotherapy. RESULTS: Of 8 patients who had low-grade tumours and underwent surgery alone, 3 had systemic relapse. Of the 22 having high-grade tumours, 4 did not receive chemotherapy because of age and comorbid conditions. Of the other 18, 13 received 3 courses of chemotherapy preoperatively and 3 courses postoperatively, 4 received all 6 courses postoperatively and 1 received all chemotherapy preoperatively to treat metastatic disease. In the 17-patient cohort used for comparison with the literature control group, disease-free survival was 57% at a mean follow-up of 25.6 months and overall survival was 57% at a mean follow-up of 30.1 months. In the control group, disease-free survival was 16% at a mean follow-up of 20.9 months and overall survival was 26% at a mean follow-up of 29.9 months. These differences are significant: p = 0.0000, chi 2 = 41.61 for disease-free survival and p = 0.0000, chi 2 = 46.49 for overall survival. CONCLUSIONS: The findings of this study support the use of adjuvant chemotherapy in patients with high-grade non-OSA, in whom malignant fibrous histiocytoma was the predominant histologic subtype.  (+info)

Brain metastases in musculoskeletal sarcomas. (6/307)

BACKGROUND: In musculoskeletal sarcomas, brain metastases are rare, but severely affect quality of life. METHODS: All patients with musculoskeletal sarcomas who were treated at our institutions from 1975 to 1997 were reviewed for examples of brain metastasis. RESULTS: Of 480 sarcoma patients, 179 had distant metastases, including 20 patients with brain metastases (4.2%). Alveolar soft part sarcoma (3/4), extraskeletal Ewing's sarcoma (2/8), rhabdomyosarcoma (2/13) and bone Ewing's sarcoma (2/18) tended to metastasize to the brain. All 20 patients had distant or local relapses and 16 of the 20 patients had pulmonary metastases. Three patients underwent surgical treatment and two of them survived over 1 year. Mean survival after diagnosis of brain metastasis was 5.1 months. CONCLUSIONS: Patients with alveolar soft part sarcoma, Ewing's sarcoma, rhabdomyosarcoma and pulmonary metastases have a high risk of brain metastasis.  (+info)

Curcumin mediated apoptosis in AK-5 tumor cells involves the production of reactive oxygen intermediates. (7/307)

Curcumin, the active ingredient of the rhizome of Curcuma longa has anti-inflammatory, antioxidant and antiproliferative activities. Although its precise mode of action remains elusive, studies have shown that chemopreventive action of curcumin might be due to its ability to induce apoptosis in cancer cells. Curcumin was shown to be responsible for the inhibition of AK-5 tumor (a rat histiocytoma) growth by inducing apoptosis in AK-5 tumor cells via caspase activation. This study was designed to investigate the mechanism leading to the induction of apoptosis in AK-5 tumor cells. Curcumin treatment resulted in the hyperproduction of reactive oxygen species (ROS), loss of mitochondrial membrane potential (delta psi(m)) and cytochrome c release to the cytosol, with the concomitant exposure of phosphatidylserine (PS) residues on the cell surface. This study suggests redox signalling and caspase activation as the mechanisms responsible for the induction of curcumin mediated apoptosis in AK-5 tumor cells.  (+info)

Molecular alterations in bone and soft-tissue sarcoma. (8/307)

Understanding the molecular alterations evident in human cancer offers the potential for more meaningful diagnosis and more accurate prediction of cancer risk as well as the hope of developing novel therapies. In this review, several of the molecular abnormalities identified in both bone and soft-tissue sarcoma are outlined. Some sarcomas exhibit consistent gene translocations, which produce a unique oncoprotein that can serve as a molecular fingerprint for the sarcoma subtype. Mutations in tumour suppressor genes result in cell proliferation that is not regulated by normal cell cycle control genes. Amplification (multiple copies) of genes that act as positive controls on cell division have a similar effect on increasing cell proliferation. Finally, the understanding of drug resistance and sarcoma response to signalling systems such as IGF ligand and receptors may help in designing new therapies based on molecular changes in the cancer.  (+info)

Benign fibrous histiocytoma (BFH) is a common benign tumor of the skin and superficial soft tissues. It primarily affects middle-aged adults and is more prevalent in men than women. The exact cause of BFH is unknown, but it's thought to arise from dermal fibroblasts or histiocytes.

Medical Definition: Benign Fibrous Histiocytoma (BFH) is a benign, slowly growing, solitary cutaneous or subcutaneous nodular tumor predominantly composed of a mixture of fibroblastic and histiocytic-like cells. The tumor typically presents as a well-circumscribed, firm, dome-shaped papule or nodule, ranging in size from a few millimeters to several centimeters. Histologically, BFH is characterized by the proliferation of spindle-shaped fibroblasts and histiocytes arranged in a storiform pattern, along with variable amounts of collagen deposition, multinucleated giant cells, and hemosiderin deposits. The lesion usually has a pushing border with no invasion into the surrounding tissues. BFH generally follows a benign clinical course, with local recurrence being uncommon following complete surgical excision.

Malignant fibrous histiocytoma (MFH) is not a specific type of histiocytoma; rather, it is a type of soft tissue sarcoma. Histiocytomas are benign tumors that arise from cells called histiocytes, which are part of the immune system. MFH, on the other hand, is a malignant (cancerous) tumor that can arise in various types of soft tissues, such as muscle, fat, tendons, and ligaments.

MFH was once thought to originate from histiocytes, but more recent research suggests that it may actually arise from undifferentiated mesenchymal cells, which are capable of developing into a variety of different cell types. MFH is the most common type of soft tissue sarcoma in adults over the age of 50 and typically presents as a painless mass in the extremities or retroperitoneum (the area in the back of the abdomen).

The tumor is characterized by the presence of fibroblastic and histiocytic-like cells, which can be quite pleomorphic (varied in shape and size) and may contain numerous mitotic figures (indicating rapid cell division). Treatment typically involves surgical excision, often followed by radiation therapy and/or chemotherapy. The prognosis for MFH depends on several factors, including the tumor's location, size, grade (degree of differentiation), and the patient's age and overall health.

Histiocytoma is a general term used to describe a group of disorders characterized by an abnormal accumulation or proliferation of histiocytes, which are a type of immune cell. These cells normally play a role in fighting infection and helping to heal wounds. However, when they multiply excessively, they can form tumors known as histiocytomas.

There are several types of histiocytomas, including:

1. Cutaneous histiocytoma: This is the most common type of histiocytoma, which typically appears as a small, raised, hairless, and pink or red bump on the skin. It usually affects dogs, but can also occur in cats and rarely in humans. These tumors are benign and often regress spontaneously within a few months.
2. Systemic histiocytoses: These are less common types of histiocytomas that involve multiple organs and tissues throughout the body. They can be further classified into several subtypes, such as Langerhans cell histiocytosis (LCH), Erdheim-Chester disease (ECD), and malignant histiocytosis. These conditions can range from benign to malignant and may require aggressive treatment, including chemotherapy or radiation therapy.

It is important to note that while histiocytomas are generally benign, they can sometimes mimic other more serious conditions. Therefore, it is essential to have any suspicious growths evaluated by a veterinarian or healthcare professional for proper diagnosis and management.

Soft tissue neoplasms refer to abnormal growths or tumors that develop in the soft tissues of the body. Soft tissues include muscles, tendons, ligaments, fascia, nerves, blood vessels, fat, and synovial membranes (the thin layer of cells that line joints and tendons). Neoplasms can be benign (non-cancerous) or malignant (cancerous), and their behavior and potential for spread depend on the specific type of neoplasm.

Benign soft tissue neoplasms are typically slow-growing, well-circumscribed, and rarely spread to other parts of the body. They can often be removed surgically with a low risk of recurrence. Examples of benign soft tissue neoplasms include lipomas (fat tumors), schwannomas (nerve sheath tumors), and hemangiomas (blood vessel tumors).

Malignant soft tissue neoplasms, on the other hand, can grow rapidly, invade surrounding tissues, and may metastasize (spread) to distant parts of the body. They are often more difficult to treat than benign neoplasms and require a multidisciplinary approach, including surgery, radiation therapy, and chemotherapy. Examples of malignant soft tissue neoplasms include sarcomas, such as rhabdomyosarcoma (arising from skeletal muscle), leiomyosarcoma (arising from smooth muscle), and angiosarcoma (arising from blood vessels).

It is important to note that soft tissue neoplasms can occur in any part of the body, and their diagnosis and treatment require a thorough evaluation by a healthcare professional with expertise in this area.

Histiocytic sarcoma is a rare type of cancer that originates from histiocytes, which are cells that are part of the immune system and found in various tissues throughout the body. These cells normally function to help fight infection and remove foreign substances. In histiocytic sarcoma, there is an abnormal accumulation and proliferation of these cells, leading to the formation of tumors.

Histiocytic sarcoma can affect people of any age but is more commonly found in adults, with a slight male predominance. It can occur in various parts of the body, such as the lymph nodes, skin, soft tissues, and internal organs like the spleen, liver, and lungs. The exact cause of histiocytic sarcoma remains unknown, but it is not considered to be hereditary.

The symptoms of histiocytic sarcoma depend on the location and extent of the tumor(s). Common signs include swollen lymph nodes, fatigue, fever, weight loss, night sweats, and pain or discomfort in the affected area. Diagnosis typically involves a combination of imaging studies (like CT scans, PET scans, or MRI), biopsies, and laboratory tests to confirm the presence of histiocytic sarcoma and assess its extent.

Treatment for histiocytic sarcoma usually involves a multidisciplinary approach, including surgery, radiation therapy, and chemotherapy. The choice of treatment depends on several factors, such as the location and stage of the disease, the patient's overall health, and their personal preferences. Clinical trials may also be an option for some patients, allowing them to access new and experimental therapies.

Prognosis for histiocytic sarcoma is generally poor, with a five-year survival rate of approximately 15-30%. However, outcomes can vary significantly depending on individual factors, such as the patient's age, the extent of the disease at diagnosis, and the effectiveness of treatment. Continued research is necessary to improve our understanding of this rare cancer and develop more effective therapies for those affected.

Sarcoma is a type of cancer that develops from certain types of connective tissue (such as muscle, fat, fibrous tissue, blood vessels, or nerves) found throughout the body. It can occur in any part of the body, but it most commonly occurs in the arms, legs, chest, and abdomen.

Sarcomas are classified into two main groups: bone sarcomas and soft tissue sarcomas. Bone sarcomas develop in the bones, while soft tissue sarcomas develop in the soft tissues of the body, such as muscles, tendons, ligaments, fat, blood vessels, and nerves.

Sarcomas can be further classified into many subtypes based on their specific characteristics, such as the type of tissue they originate from, their genetic makeup, and their appearance under a microscope. The different subtypes of sarcoma have varying symptoms, prognoses, and treatment options.

Overall, sarcomas are relatively rare cancers, accounting for less than 1% of all cancer diagnoses in the United States each year. However, they can be aggressive and may require intensive treatment, such as surgery, radiation therapy, and chemotherapy.

Skull neoplasms refer to abnormal growths or tumors that develop within the skull. These growths can be benign (non-cancerous) or malignant (cancerous). They can originate from various types of cells, such as bone cells, nerve cells, or soft tissues. Skull neoplasms can cause various symptoms depending on their size and location, including headaches, seizures, vision problems, hearing loss, and neurological deficits. Treatment options include surgery, radiation therapy, and chemotherapy. It is important to note that a neoplasm in the skull can also refer to metastatic cancer, which has spread from another part of the body to the skull.

Liposarcoma is a type of soft tissue sarcoma, which is a cancer that develops in the soft tissues of the body, such as fat, muscle, nerves, blood vessels, and fibrous tissues. Specifically, liposarcoma arises from fat cells (adipocytes) or their precursors.

There are several subtypes of liposarcoma, which differ in their appearance under the microscope, genetic features, and clinical behavior. These include well-differentiated, dedifferentiated, myxoid, round cell, and pleomorphic liposarcomas. The most common sites for liposarcoma are the thigh, retroperitoneum (the area behind the abdominal cavity), and the buttock.

Liposarcomas can grow slowly or rapidly, and they may spread to other parts of the body (metastasize) through the bloodstream or lymphatic system. Treatment typically involves surgical removal of the tumor, often followed by radiation therapy and/or chemotherapy. The prognosis for liposarcoma depends on several factors, including the type and grade of the tumor, its size and location, and whether it has spread to other parts of the body.

Retroperitoneal neoplasms refer to abnormal growths or tumors that develop in the retroperitoneal space. This is the area located behind the peritoneum, which is the membrane that lines the abdominal cavity and covers the abdominal organs. The retroperitoneal space contains several vital structures such as the kidneys, adrenal glands, pancreas, aorta, and lymphatic vessels.

Retroperitoneal neoplasms can be benign or malignant (cancerous). Malignant retroperitoneal neoplasms are often aggressive and can invade surrounding tissues and organs, leading to various complications. Common types of retroperitoneal neoplasms include lymphomas, sarcomas, and metastatic tumors from other primary sites. Symptoms may vary depending on the size and location of the tumor but can include abdominal or back pain, weight loss, and swelling in the legs. Diagnosis typically involves imaging studies such as CT scans or MRI, followed by a biopsy to determine the type and grade of the tumor. Treatment options may include surgery, radiation therapy, chemotherapy, or a combination of these approaches.

Femoral neoplasms refer to abnormal growths or tumors that develop in the femur, which is the long thigh bone in the human body. These neoplasms can be benign (non-cancerous) or malignant (cancerous). Benign femoral neoplasms are slow-growing and rarely spread to other parts of the body, while malignant neoplasms are aggressive and can invade nearby tissues and organs, as well as metastasize (spread) to distant sites.

There are various types of femoral neoplasms, including osteochondromas, enchondromas, chondrosarcomas, osteosarcomas, and Ewing sarcomas, among others. The specific type of neoplasm is determined by the cell type from which it arises and its behavior.

Symptoms of femoral neoplasms may include pain, swelling, stiffness, or weakness in the thigh, as well as a palpable mass or limited mobility. Diagnosis typically involves imaging studies such as X-rays, CT scans, or MRI, as well as biopsy to determine the type and grade of the tumor. Treatment options may include surgery, radiation therapy, chemotherapy, or a combination of these approaches, depending on the type, size, location, and stage of the neoplasm.

Angiomatosis is a medical term that refers to a benign condition characterized by the proliferation of blood vessels in various tissues and organs. It is typically composed of small, tangled blood vessels called capillaries, which can form clusters or networks. The condition can affect skin, internal organs, bones, and other tissues.

Angiomatosis is often asymptomatic and may be discovered incidentally during medical imaging or surgical procedures. In some cases, it may cause symptoms such as pain, swelling, or bleeding, depending on the location and extent of the lesions.

While angiomatosis is generally a benign condition, in rare cases, it can be associated with malignant tumors or other medical conditions. Treatment options for angiomatosis depend on the size, location, and symptoms of the lesions and may include observation, medication, or surgical removal.

Myxosarcoma is a very rare type of soft tissue sarcoma, a cancer that develops in the soft tissues of the body, such as fat, muscle, nerves, blood vessels, and fibrous tissues. Myxosarcomas are characterized by the presence of mucoid or gelatinous material in the tumor, which is composed of an abnormal accumulation of acid mucopolysaccharides. These tumors typically affect adults, with a peak incidence in the sixth to seventh decade of life. They usually occur in the extremities, particularly the lower limbs, and can also arise in the retroperitoneum or other deep soft tissues. Myxosarcomas are classified into several subtypes based on their histological features, with the most common being the myxofibrosarcoma. Treatment typically involves surgical resection with wide margins, often followed by radiation therapy and/or chemotherapy. The prognosis for patients with myxosarcoma depends on several factors, including the size and location of the tumor, the histological grade, and the patient's age and overall health.

Piezosurgery is a type of surgical procedure that uses ultrasonic vibrations to cut through bone tissue while minimizing damage to surrounding soft tissues. It is often used in oral and maxillofacial surgery, such as during dental implant placement or jaw osteotomies. The piezoelectric instrument generates high-frequency microvibrations that selectively cut mineralized tissue like bone, while leaving adjacent soft tissues largely unaffected. This allows for precise cuts with less trauma and bleeding compared to traditional surgical techniques, potentially resulting in faster healing times and reduced postoperative discomfort.

Vascular neoplasms are a type of tumor that develops from cells that line the blood vessels or lymphatic vessels. These tumors can be benign (non-cancerous) or malignant (cancerous). Benign vascular neoplasms, such as hemangiomas and lymphangiomas, are usually harmless and may not require treatment unless they cause symptoms or complications. Malignant vascular neoplasms, on the other hand, are known as angiosarcomas and can be aggressive, spreading to other parts of the body and potentially causing serious health problems.

Angiosarcomas can develop in any part of the body but are most commonly found in the skin, particularly in areas exposed to radiation or chronic lymph edema. They can also occur in the breast, liver, spleen, and heart. Treatment for vascular neoplasms depends on the type, location, size, and stage of the tumor, as well as the patient's overall health. Treatment options may include surgery, radiation therapy, chemotherapy, or a combination of these approaches.

Heart neoplasms are abnormal growths or tumors that develop within the heart tissue. They can be benign (noncancerous) or malignant (cancerous). Benign tumors, such as myxomas and rhabdomyomas, are typically slower growing and less likely to spread, but they can still cause serious complications if they obstruct blood flow or damage heart valves. Malignant tumors, such as angiosarcomas and rhabdomyosarcomas, are fast-growing and have a higher risk of spreading to other parts of the body. Symptoms of heart neoplasms can include shortness of breath, chest pain, fatigue, and irregular heart rhythms. Treatment options depend on the type, size, and location of the tumor, and may include surgery, radiation therapy, or chemotherapy.

Bone neoplasms are abnormal growths or tumors that develop in the bone. They can be benign (non-cancerous) or malignant (cancerous). Benign bone neoplasms do not spread to other parts of the body and are rarely a threat to life, although they may cause problems if they grow large enough to press on surrounding tissues or cause fractures. Malignant bone neoplasms, on the other hand, can invade and destroy nearby tissue and may spread (metastasize) to other parts of the body.

There are many different types of bone neoplasms, including:

1. Osteochondroma - a benign tumor that develops from cartilage and bone
2. Enchondroma - a benign tumor that forms in the cartilage that lines the inside of the bones
3. Chondrosarcoma - a malignant tumor that develops from cartilage
4. Osteosarcoma - a malignant tumor that develops from bone cells
5. Ewing sarcoma - a malignant tumor that develops in the bones or soft tissues around the bones
6. Giant cell tumor of bone - a benign or occasionally malignant tumor that develops from bone tissue
7. Fibrosarcoma - a malignant tumor that develops from fibrous tissue in the bone

The symptoms of bone neoplasms vary depending on the type, size, and location of the tumor. They may include pain, swelling, stiffness, fractures, or limited mobility. Treatment options depend on the type and stage of the tumor but may include surgery, radiation therapy, chemotherapy, or a combination of these treatments.

Genital neoplasms in males refer to abnormal growths or tumors that develop in the male reproductive organs. These can be benign (non-cancerous) or malignant (cancerous).

Malignant genital neoplasms are often referred to as genital cancers. The most common types of male genital cancers include:

1. Penile Cancer: This occurs when cancer cells form in the tissues of the penis.
2. Testicular Cancer: This forms in the testicles (testes), which are located inside the scrotum.
3. Prostate Cancer: This is a common cancer in men, forming in the prostate gland, which is part of the male reproductive system that helps make semen.
4. Scrotal Cancer: This is a rare form of cancer that forms in the skin or tissue of the scrotum.
5. Penile Intraepithelial Neoplasia (PeIN): This is not cancer, but it is considered a pre-cancerous condition of the penis.

Early detection and treatment of genital neoplasms can significantly improve the prognosis. Regular self-examinations and medical check-ups are recommended, especially for individuals with risk factors such as smoking, HIV infection, or a family history of these cancers.

Tracheobronchomegaly is a rare condition characterized by an abnormal dilatation or widening of the trachea and bronchi, which are the airway tubes leading to the lungs. This condition is also known as Mounier-Kuhn syndrome. It is typically associated with recurrent respiratory infections, coughing, and difficulty breathing, especially during physical exertion. The exact cause of tracheobronchomegaly is not well understood, but it may be related to a congenital abnormality or connective tissue disorder. Diagnosis is often made through imaging studies such as chest X-rays or CT scans. Treatment typically involves managing symptoms and preventing complications, and may include bronchodilators, antibiotics, and respiratory therapy. In severe cases, surgery may be necessary to repair or reinforce the airway walls.

A fatal outcome is a term used in medical context to describe a situation where a disease, injury, or illness results in the death of an individual. It is the most severe and unfortunate possible outcome of any medical condition, and is often used as a measure of the severity and prognosis of various diseases and injuries. In clinical trials and research, fatal outcome may be used as an endpoint to evaluate the effectiveness and safety of different treatments or interventions.

There is no medical definition for "dog diseases" as it is too broad a term. However, dogs can suffer from various health conditions and illnesses that are specific to their species or similar to those found in humans. Some common categories of dog diseases include:

1. Infectious Diseases: These are caused by viruses, bacteria, fungi, or parasites. Examples include distemper, parvovirus, kennel cough, Lyme disease, and heartworms.
2. Hereditary/Genetic Disorders: Some dogs may inherit certain genetic disorders from their parents. Examples include hip dysplasia, elbow dysplasia, progressive retinal atrophy (PRA), and degenerative myelopathy.
3. Age-Related Diseases: As dogs age, they become more susceptible to various health issues. Common age-related diseases in dogs include arthritis, dental disease, cancer, and cognitive dysfunction syndrome (CDS).
4. Nutritional Disorders: Malnutrition or improper feeding can lead to various health problems in dogs. Examples include obesity, malnutrition, and vitamin deficiencies.
5. Environmental Diseases: These are caused by exposure to environmental factors such as toxins, allergens, or extreme temperatures. Examples include heatstroke, frostbite, and toxicities from ingesting harmful substances.
6. Neurological Disorders: Dogs can suffer from various neurological conditions that affect their nervous system. Examples include epilepsy, intervertebral disc disease (IVDD), and vestibular disease.
7. Behavioral Disorders: Some dogs may develop behavioral issues due to various factors such as anxiety, fear, or aggression. Examples include separation anxiety, noise phobias, and resource guarding.

It's important to note that regular veterinary care, proper nutrition, exercise, and preventative measures can help reduce the risk of many dog diseases.

Spontaneous neoplasm regression is a rare and somewhat controversial phenomenon in which a tumor or malignancy appears to decrease in size or disappear without any treatment or with treatment that is typically not expected to produce such an effect. This can occur through various mechanisms, including immune-mediated processes, apoptosis (programmed cell death), differentiation of cancer cells into normal cells, and angiogenesis inhibition (preventing the growth of new blood vessels that feed the tumor).

Spontaneous regression of neoplasms is not well understood and is considered unpredictable. It has been reported in various types of cancers, including neuroblastoma, melanoma, renal cell carcinoma, and others. However, it should be noted that spontaneous regression does not imply a cure, as the tumor may still recur or metastasize later on.

In summary, spontaneous neoplasm regression refers to the partial or complete disappearance of a malignancy without any specific treatment or with treatment that is not typically associated with such an effect.

In the context of human anatomy, the thigh is the part of the lower limb that extends from the hip to the knee. It is the upper and largest portion of the leg and is primarily composed of the femur bone, which is the longest and strongest bone in the human body, as well as several muscles including the quadriceps femoris (front thigh), hamstrings (back thigh), and adductors (inner thigh). The major blood vessels and nerves that supply the lower limb also pass through the thigh.

Giant cell tumors (GCTs) are a type of benign or rarely malignant bone tumor that is characterized by the presence of multinucleated giant cells. These tumors typically affect adults between the ages of 20 and 40, and they can occur in any bone, but they most commonly involve the long bones near the knee joint.

GCTs are composed of three types of cells: mononuclear stromal cells, which produce the matrix of the tumor; multinucleated osteoclast-like giant cells, which resemble the bone-resorbing cells found in normal bone; and macrophages, which are part of the body's immune system.

The mononuclear stromal cells produce a variety of growth factors that stimulate the formation and activity of the osteoclast-like giant cells, leading to localized bone destruction. The tumor may cause pain, swelling, and limited mobility in the affected area.

While GCTs are typically benign, they can be aggressive and locally destructive, with a tendency to recur after surgical removal. In some cases, GCTs may undergo malignant transformation, leading to the development of sarcomas. Treatment options for GCTs include curettage (scraping out) of the tumor, followed by bone grafting or the use of a cement spacer to fill the defect, and/or adjuvant therapy with radiation or chemotherapy.

A fibroma is a benign (non-cancerous) tumor that consists primarily of fibrous or connective tissue. It can occur in various parts of the body, including the skin, mouth, and internal organs. The term "fibroma" is often used to describe any benign fibrous growth, but there are specific types of fibromas such as dermatofibroma (found in the skin), oral fibroma (found in the mouth), and benign fibrous histiocytoma (found in soft tissues).

It's important to note that while fibromas are generally harmless, they can cause discomfort or problems depending on their size and location. If a fibroma is causing issues or there's concern about its growth or malignancy, it should be evaluated by a healthcare professional for potential removal or further assessment.

Histiocytes are a type of immune cell that are part of the mononuclear phagocyte system. They originate from monocytes, which are derived from hematopoietic stem cells in the bone marrow. Histiocytes play an important role in the immune system by engulfing and destroying foreign substances, such as bacteria and viruses, as well as removing dead cells and other debris from the body. They can be found in various tissues throughout the body, including the skin, lymph nodes, spleen, and liver.

Histiocytes include several different types of cells, such as macrophages, dendritic cells, and Langerhans cells. These cells have different functions but all play a role in the immune response. For example, macrophages are involved in inflammation and tissue repair, while dendritic cells are important for presenting antigens to T cells and initiating an immune response.

Abnormal accumulations or dysfunction of histiocytes can lead to various diseases, such as histiocytosis, which is a group of disorders characterized by the abnormal proliferation and accumulation of histiocytes in various tissues.

Maxillary sinus neoplasms refer to abnormal growths or tumors that develop in the maxillary sinuses, which are located in the upper part of your cheekbones, below your eyes. These growths can be benign (non-cancerous) or malignant (cancerous).

Benign neoplasms may include conditions such as an osteoma (a benign bone tumor), a papilloma (a benign growth of the lining of the sinus), or a fibrous dysplasia (a condition where bone is replaced by fibrous tissue).

Malignant neoplasms, on the other hand, can be primary (originating in the maxillary sinuses) or secondary (spreading to the maxillary sinuses from another site in the body). Common types of malignant tumors that arise in the maxillary sinus include squamous cell carcinoma, adenocarcinoma, and mucoepidermoid carcinoma.

Symptoms of maxillary sinus neoplasms may include nasal congestion, nosebleeds, facial pain or numbness, vision changes, and difficulty swallowing or speaking. Treatment options depend on the type, size, and location of the tumor but may include surgery, radiation therapy, chemotherapy, or a combination of these approaches.

Immunohistochemistry (IHC) is a technique used in pathology and laboratory medicine to identify specific proteins or antigens in tissue sections. It combines the principles of immunology and histology to detect the presence and location of these target molecules within cells and tissues. This technique utilizes antibodies that are specific to the protein or antigen of interest, which are then tagged with a detection system such as a chromogen or fluorophore. The stained tissue sections can be examined under a microscope, allowing for the visualization and analysis of the distribution and expression patterns of the target molecule in the context of the tissue architecture. Immunohistochemistry is widely used in diagnostic pathology to help identify various diseases, including cancer, infectious diseases, and immune-mediated disorders.

Orbital neoplasms refer to abnormal growths or tumors that develop in the orbit, which is the bony cavity that contains the eyeball, muscles, nerves, fat, and blood vessels. These neoplasms can be benign (non-cancerous) or malignant (cancerous), and they can arise from various types of cells within the orbit.

Orbital neoplasms can cause a variety of symptoms depending on their size, location, and rate of growth. Common symptoms include protrusion or displacement of the eyeball, double vision, limited eye movement, pain, swelling, and numbness in the face. In some cases, orbital neoplasms may not cause any noticeable symptoms, especially if they are small and slow-growing.

There are many different types of orbital neoplasms, including:

1. Optic nerve glioma: a rare tumor that arises from the optic nerve's supportive tissue.
2. Orbital meningioma: a tumor that originates from the membranes covering the brain and extends into the orbit.
3. Lacrimal gland tumors: benign or malignant growths that develop in the lacrimal gland, which produces tears.
4. Orbital lymphangioma: a non-cancerous tumor that arises from the lymphatic vessels in the orbit.
5. Rhabdomyosarcoma: a malignant tumor that develops from the skeletal muscle cells in the orbit.
6. Metastatic tumors: cancerous growths that spread to the orbit from other parts of the body, such as the breast, lung, or prostate.

The diagnosis and treatment of orbital neoplasms depend on several factors, including the type, size, location, and extent of the tumor. Imaging tests, such as CT scans and MRI, are often used to visualize the tumor and determine its extent. A biopsy may also be performed to confirm the diagnosis and determine the tumor's type and grade. Treatment options include surgery, radiation therapy, chemotherapy, or a combination of these approaches.

Skin neoplasms refer to abnormal growths or tumors in the skin that can be benign (non-cancerous) or malignant (cancerous). They result from uncontrolled multiplication of skin cells, which can form various types of lesions. These growths may appear as lumps, bumps, sores, patches, or discolored areas on the skin.

Benign skin neoplasms include conditions such as moles, warts, and seborrheic keratoses, while malignant skin neoplasms are primarily classified into melanoma, squamous cell carcinoma, and basal cell carcinoma. These three types of cancerous skin growths are collectively known as non-melanoma skin cancers (NMSCs). Melanoma is the most aggressive and dangerous form of skin cancer, while NMSCs tend to be less invasive but more common.

It's essential to monitor any changes in existing skin lesions or the appearance of new growths and consult a healthcare professional for proper evaluation and treatment if needed.

Dermatofibrosarcoma protuberans (DFSP) is a rare type of skin cancer that begins in the middle layer of the skin known as the dermis. It often appears as a scar or bruise that does not go away and may grow slowly over time, sometimes spreading to deeper tissues and other parts of the body. DFSP can be difficult to treat if it has spread, but when caught early, it is usually curable with surgery.

DFSP is characterized by the growth of abnormal fibroblasts, which are cells that produce collagen, a protein that helps make up connective tissues in the body. The exact cause of DFSP is not known, but it has been linked to genetic mutations and previous injuries or surgeries to the skin.

Treatment for DFSP typically involves surgical removal of the tumor, along with a margin of healthy tissue around it. In some cases, radiation therapy or targeted therapy may also be used to help ensure that all cancer cells have been removed. Regular follow-up care is important to monitor for any signs of recurrence or spread of the disease.

X-ray computed tomography (CT or CAT scan) is a medical imaging method that uses computer-processed combinations of many X-ray images taken from different angles to produce cross-sectional (tomographic) images (virtual "slices") of the body. These cross-sectional images can then be used to display detailed internal views of organs, bones, and soft tissues in the body.

The term "computed tomography" is used instead of "CT scan" or "CAT scan" because the machines take a series of X-ray measurements from different angles around the body and then use a computer to process these data to create detailed images of internal structures within the body.

CT scanning is a noninvasive, painless medical test that helps physicians diagnose and treat medical conditions. CT imaging provides detailed information about many types of tissue including lung, bone, soft tissue and blood vessels. CT examinations can be performed on every part of the body for a variety of reasons including diagnosis, surgical planning, and monitoring of therapeutic responses.

In computed tomography (CT), an X-ray source and detector rotate around the patient, measuring the X-ray attenuation at many different angles. A computer uses this data to construct a cross-sectional image by the process of reconstruction. This technique is called "tomography". The term "computed" refers to the use of a computer to reconstruct the images.

CT has become an important tool in medical imaging and diagnosis, allowing radiologists and other physicians to view detailed internal images of the body. It can help identify many different medical conditions including cancer, heart disease, lung nodules, liver tumors, and internal injuries from trauma. CT is also commonly used for guiding biopsies and other minimally invasive procedures.

In summary, X-ray computed tomography (CT or CAT scan) is a medical imaging technique that uses computer-processed combinations of many X-ray images taken from different angles to produce cross-sectional images of the body. It provides detailed internal views of organs, bones, and soft tissues in the body, allowing physicians to diagnose and treat medical conditions.

Osteosarcoma is defined as a type of cancerous tumor that arises from the cells that form bones (osteoblasts). It's the most common primary bone cancer, and it typically develops in the long bones of the body, such as the arms or legs, near the growth plates. Osteosarcoma can metastasize (spread) to other parts of the body, including the lungs, making it a highly malignant form of cancer. Symptoms may include bone pain, swelling, and fractures. Treatment usually involves a combination of surgery, chemotherapy, and/or radiation therapy.

Cystadenocarcinoma is a type of tumor that arises from the epithelial lining of a cyst, and it has the potential to invade surrounding tissues and spread (metastasize) to other parts of the body. It typically affects glandular organs such as the ovaries, pancreas, and salivary glands.

Cystadenocarcinomas can be classified into two types: serous and mucinous. Serous cystadenocarcinomas produce a watery fluid, while mucinous cystadenocarcinomas produce a thick, mucus-like fluid. Both types of tumors can be benign or malignant, but malignant cystadenocarcinomas are more aggressive and have a higher risk of metastasis.

Symptoms of cystadenocarcinoma depend on the location and size of the tumor. In some cases, there may be no symptoms until the tumor has grown large enough to cause pain or other problems. Treatment typically involves surgical removal of the tumor, along with any affected surrounding tissue. Chemotherapy and radiation therapy may also be used in some cases to help prevent recurrence or spread of the cancer.

Leiomyosarcoma is a type of cancer that arises from the smooth muscle cells, which are responsible for the involuntary contractions of various organs and blood vessels. It most commonly occurs in the uterus, soft tissues (such as muscles and fat), and the gastrointestinal tract.

Leiomyosarcomas can vary in their aggressiveness and may spread to other parts of the body (metastasize) through the bloodstream or lymphatic system. The prognosis for leiomyosarcoma depends on several factors, including the location and size of the tumor, the patient's age and overall health, and the extent of metastasis. Treatment typically involves surgical removal of the tumor, along with radiation therapy and/or chemotherapy to help prevent recurrence or spread of the cancer.

Multiple primary neoplasms refer to the occurrence of more than one primary malignant tumor in an individual, where each tumor is unrelated to the other and originates from separate cells or organs. This differs from metastatic cancer, where a single malignancy spreads to multiple sites in the body. Multiple primary neoplasms can be synchronous (occurring at the same time) or metachronous (occurring at different times). The risk of developing multiple primary neoplasms increases with age and is associated with certain genetic predispositions, environmental factors, and lifestyle choices such as smoking and alcohol consumption.

Chondrosarcoma is a type of cancer that develops in the cartilaginous tissue, which is the flexible and smooth connective tissue found in various parts of the body such as the bones, ribs, and nose. It is characterized by the production of malignant cartilage cells that can invade surrounding tissues and spread to other parts of the body (metastasis).

Chondrosarcomas are typically slow-growing tumors but can be aggressive in some cases. They usually occur in adults over the age of 40, and men are more commonly affected than women. The most common sites for chondrosarcoma development include the bones of the pelvis, legs, and arms.

Treatment for chondrosarcoma typically involves surgical removal of the tumor, along with radiation therapy or chemotherapy in some cases. The prognosis for chondrosarcoma depends on several factors, including the size and location of the tumor, the grade of malignancy, and whether it has spread to other parts of the body.

Mediastinal neoplasms refer to abnormal growths or tumors located in the mediastinum, which is the central compartment of the thoracic cavity that lies between the lungs and contains various vital structures such as the heart, esophagus, trachea, blood vessels, lymph nodes, and nerves. Mediastinal neoplasms can be benign (non-cancerous) or malignant (cancerous), and they can arise from any of the tissues or organs within the mediastinum.

Benign mediastinal neoplasms may include thymomas, lipomas, neurofibromas, or teratomas, among others. These tumors are typically slow-growing and rarely spread to other parts of the body. However, they can still cause symptoms or complications by compressing adjacent structures within the mediastinum, such as the airways, blood vessels, or nerves.

Malignant mediastinal neoplasms are cancerous tumors that can invade and destroy surrounding tissues and may spread (metastasize) to other parts of the body. Common types of malignant mediastinal neoplasms include thymic carcinomas, lymphomas, germ cell tumors, and neuroendocrine tumors. These tumors often require aggressive treatment, such as surgery, radiation therapy, and chemotherapy, to control their growth and spread.

It is important to note that mediastinal neoplasms can present with various symptoms depending on their location, size, and type. Some patients may be asymptomatic, while others may experience cough, chest pain, difficulty breathing, hoarseness, or swallowing difficulties. A thorough diagnostic workup, including imaging studies and biopsies, is necessary to confirm the diagnosis and determine the best course of treatment for mediastinal neoplasms.

Types include: benign fibrous histiocytoma: This tumor has also been termed benign fibrous histiocytomas of the skin, ... superficial/cutaneous benign fibrous histiocytomas, common fibrous histiocytoma, and more recently dermatofibroma. The use of " ... "Benign fibrous histiocytoma of the oral and maxillofacial region: A systematic review". Oral Surgery, Oral Medicine, Oral ... Wu Y, Liu X, Lv Y, Li Z (July 2021). "Malignant fibrous histiocytoma of the floor of mouth: a case report and review of the ...
Benign fibrous histiocytoma Dermatofibrosarcoma protuberans Fibrous connective tissue Fibroma Malignant fibrous histiocytoma ... It originates in fibrous tissues of the bone and invades long or flat bones such as the femur, tibia, and mandible. It also ... Fibrosarcoma (fibroblastic sarcoma) is a malignant mesenchymal tumour derived from fibrous connective tissue and characterized ...
... benign fibrous histiocytoma, dermal dendrocytoma, fibrous dermatofibroma, fibrous histiocytoma, fibroma simplex, histiocytoma, ... Fibrous hamartoma of infancy Fibrous papule of the nose (benign solitary fibrous papule, fibrous papule of the face) Folded ... Lymphangiomatosis Malignant fibrous histiocytoma Malignant peripheral nerve sheath tumor (malignant schwannoma, ... Familial benign chronic pemphigus (familial benign pemphigus, Hailey-Hailey disease) Fanconi syndrome (familial pancytopenia, ...
... histiocytoma, benign fibrous MeSH C04.557.450.565.590.425.360 - histiocytoma, malignant fibrous MeSH C04.557.450.565.590.550 - ... histiocytoma, malignant fibrous MeSH C04.557.450.795.455 - leiomyosarcoma MeSH C04.557.450.795.465 - liposarcoma MeSH C04.557. ... fibrous tissue MeSH C04.557.450.565.590.340 - fibroma MeSH C04.557.450.565.590.340.345 - fibroma, desmoplastic MeSH C04.557. ...
... also termed malignant fibrous histiocytoma), rhabdomyosarcoma, or other types of sarcoma and treated unnecessarily with ... That is, they are examples of "transient neoplasms." In all events, PF/PM lesions are benign tumor growths that do not ... Proliferative fasciitis and proliferative myositis (PF/PM) are rare benign soft tissue lesions (i.e. a damaged or unspecified ... Articles with short description, Short description matches Wikidata, Connective and soft tissue neoplasms, Benign neoplasms). ...
Leiomyosarcoma Fibrous histiocytoma Proximal epithelioid sarcoma Alveolar soft part sarcoma Liposarcoma Dermatofibrosarcoma ... While cancer is by definition malignant, a tumor can be benign, precancerous, or malignant. "Benign Neoplasms of the Vulva , ... They can be benign or malignant (vulvar cancer). Vulvar neoplasms are divided into cystic or solid lesions and other mixed ... There are four main groups of vaginal neoplasms: benign neoplasms, in situ neoplasms, malignant neoplasms, and neoplasms of ...
While malignant fibrous histiocytoma (MFH) - now generally called "pleomorphic undifferentiated sarcoma" - primary in bone is ... Common benign bone tumors may be neoplastic, developmental, traumatic, infectious, or inflammatory in etiology. Some benign ... The outcome is expected to be good for people with noncancerous (benign) tumors, although some types of benign tumors may ... The most common locations for many primary tumors, both benign and malignant include the distal femur and proximal tibia ( ...
... congenital peribronchial myofibroblastic tumor M8830/0 Benign fibrous histiocytoma Fibrous histiocytoma, NOS Fibroxanthoma, NOS ... benign M9050/3 Mesothelioma, malignant or NOS M9051/0 Fibrous mesothelioma, benign M9051/3 Fibrous mesothelioma, malignant or ... benign Tumor, benign Unclassified tumor, benign M8000/1 Neoplasm, uncertain whether benign or malignant Neoplasm, NOS Tumor, ... Xantofibroma M8830/1 Atypical fibrous histiocytoma Atypical fibroxanthoma M8830/3 Malignant fibrous histiocytoma Fibroxanthoma ...
... malignant fibrous histiocytoma, malignant nerve sheath tumors, myxosarcoma, myxofibrosarcoma, mesenchymoma, and spindle cell ... They tend to have similar histologic appearance and biological behavior, and can be either benign or malignant. Soft tissue ...
Fibrosarcoma-like and fibrous histiocytoma-like areas can be observed as well as neurofibromatous and neuroblastic components ... Differential diagnosis should consider rhabdomyosarcoma, Triton tumor, teratoma, Wilms tumor and benign, mature ...
Chondrosarcoma Ewing's sarcoma Malignant fibrous histiocytoma of bone/osteosarcoma Osteosarcoma Rhabdomyosarcoma Leiomyosarcoma ... For example, a benign tumor of smooth muscle cells is called a leiomyoma (the common name of this frequently occurring benign ... Benign tumors (which are not cancers) are usually named using -oma as a suffix with the organ name as the root. ... Not all tumors or lumps are cancerous; benign tumors are not classified as being cancer because they do not spread to other ...
Angiomatoid fibrous histiocytoma: The neoplastic cells in these tumors express a EWSR1-CREB1 fusion gene in most cases or a ... Arbajian E, Magnusson L, Brosjö O, Wejde J, Folpe AL, Nord KH, Mertens F (April 2013). "A benign vascular tumor with a new ... These tumors are suggested to be a variant of the angiomatoid fibrous histiocytoma tumors. By definition, the neoplastic cells ... "Distinct clinicopathological features of pulmonary primary angiomatoid fibrous histiocytoma: A report of four new cases and ...
Malignant FMTs Solitary fibrous tumor, malignant type, a malignant form of the solitary fibrous tumors Fibrosarcoma NOS, i.e. ... benign, intermediate (locally aggressive), intermediate (rarely metastasizing), and malignant. Benign FMTs Nodular fasciitis ... Myxofibrosarcoma, once classified as a histiocyte-derived histiocytoma now reclassified as a fibroblastic/myofibroblastic tumor ... Solitary fibrous tumour, also fibrous termed tumor of the pleura. Inflammatory myofibroblastic tumour Low-grade myofibroblastic ...
... such as malignant fibrous histiocytoma and rhabdomyosarcoma. In some instances, they can also bear considerable resemblance to ... Willebrand H, Wernitsch W, Elmohamed A (September 1970). "[Pulmonary metastases of a giant-cell carcinoma in the bone-benign or ... GCCL have been noted to be encapsulated, and to be divided via septa into "pseudolobules", by a highly fibrous stroma, ... the latter entity can behave as a neoplasm of benign, frankly malignant, or borderline in its clinical behavior. GCCLs are ...
Soft-tissue neoplasms such as pleomorphic undifferentiated sarcoma (malignant fibrous histiocytoma) that erode into adjacent ... The wide zone of transition (e.g. permeative) is the most useful plain film characteristic in differentiation of benign versus ...
PMX2B Histiocytoma, angiomatoid fibrous, somatic; 612160; CREB1 HMG-CoA synthase-2 deficiency; 605911; HMGCS2 Hodgkin's ... benign neonatal, type 2; 121201; KCNQ3 Epilepsy, benign, neonatal, type 1; 121200; KCNQ2 Epilepsy, female-restricted, with ... benign recurrent intrahepatic, 2; 605479; ABCB11 Cholestasis, benign recurrent intrahepatic; 243300; ATP8B1 Cholestasis, ... benign familial; 263400; VHL Polydactyly, postaxial, types A1 and B; 174200; GLI3 Polydactyly, preaxial type II; 174500; LMBR1 ...
Other malignant tumors include liposarcoma, leiomyosarcoma, malignant fibrous histiocytoma and mesothelioma.[citation needed] ... it is generally believed that these lesions represent a benign reactive proliferation of inflammatory and fibrous tissue, in ... Fibrous pseudotumor. With color Doppler, a little vascular flow is seen in this fibrous pseudotumor.[citation needed] ... 12]. Leiomyomas are benign neoplasms that may arise from any structure or organ containing smooth muscle. The majority of ...
NF may resemble and therefore be misdiagnosed as dermatofibrosarcoma protuberans, fibrosarcoma, malignant fibrous histiocytoma ... NF is the most common of the benign fibroblastic proliferative tumors of soft tissue. Nodular fasciitis is a rapidly growing, ... Nodular fasciitis (NF) is a benign, soft tissue tumor composed of myofibroblasts that typically occurs in subcutaneous tissue, ... In 2020, the World Health Organization classified nodular fasciitis as in the category of benign fibroblastic/myofibroblastic ...
... a tumor formerly termed malignant myxoid fibrous histiocytoma. PLS neoplastic cells contain various gene and chromosome ... as relatively non-aggressive and benign, all five liposarcoma forms can infiltrate locally to injure nearby tissues and organs ...
... malignant fibrous cytoma - malignant fibrous histiocytoma - malignant meningioma - malignant mesothelioma - malignant mixed ... benign - benign proliferative breast disease - benign prostatic hyperplasia - benign prostatic hypertrophy - benign tumor - ... fibrous - fifth cranial nerve - filgrastim - filgrastim-SD/01 - finasteride - fine-needle aspiration - first-line therapy - ...
Histiocytoma is a benign skin tumor that is more frequent in young dogs (. ... Cor triatriatum*, specifically cor triatriatum dexter, occurs in dogs and is characterized by a fibrous division of the right ... Reproductive diseases Prostate disease* in dogs includes benign prostatic hyperplasia (BPH), prostatitis (infection of the ... congenital disease in dogs characterized by left ventricular outflow tract obstruction by a discrete ring or tunnel of fibrous ...
Benign fibrous histiocytoma is a benign tumor composed of a mixture of fibroblastic and histiocytic cells. Based on the ... Benign fibrous histiocytoma of submandibular space. Benign fibrous histiocytoma is a benign tumor composed of a mixture of ... Non-cutaneous benign FH represents approximately 1% of all benign FH lesions. The diagnosis of benign fibrous histiocytoma ... and histopathology revealed it to be a benign fibrous histiocytoma.. Author(s): Pradipta Kumar Parida Gopalakrishnan ...
title = "Benign fibrous histiocytoma in hodgkins disease",. abstract = "A case of benign fibrous histiocytoma in a patient ... A case of benign fibrous histiocytoma in a patient with previous Hodgkins disease is reported. Benign fibrous histiocytoma ... A case of benign fibrous histiocytoma in a patient with previous Hodgkins disease is reported. Benign fibrous histiocytoma ... A case of benign fibrous histiocytoma in a patient with previous Hodgkins disease is reported. Benign fibrous histiocytoma ...
Abdellatif E. (2017). Soft tissuefibrohistiocytic tumors - Benign fibrous histiocytoma (superficial).. http://www. ... Can Benign Tumors Become Malignant?. Some types of benign tumors, such as colon polyps, have the potential to progress into ... Life After Benign Meningioma Surgery. Benign meningioma surgery comes with risk, but youll likely experience improved quality ... Acoustic neuromas are benign tumors that can form on the nerve between the brain and inner ear. They require observation and ...
Types include: benign fibrous histiocytoma: This tumor has also been termed benign fibrous histiocytomas of the skin, ... superficial/cutaneous benign fibrous histiocytomas, common fibrous histiocytoma, and more recently dermatofibroma. The use of " ... "Benign fibrous histiocytoma of the oral and maxillofacial region: A systematic review". Oral Surgery, Oral Medicine, Oral ... Wu Y, Liu X, Lv Y, Li Z (July 2021). "Malignant fibrous histiocytoma of the floor of mouth: a case report and review of the ...
Malignant fibrous histiocytoma and liposarcoma generally occur in older adults. Benign deep masses in adults usually are due to ... encoded search term (Benign and Malignant Soft-Tissue Tumors) and Benign and Malignant Soft-Tissue Tumors What to Read Next on ... Generally, soft-tissue tumors grow centripetally, though some benign tumors (eg, fibrous lesions) may grow longitudinally along ... Benign and Malignant Soft-Tissue Tumors. Updated: Apr 28, 2022 * Author: Vinod B Shidham, MD, FRCPath; Chief Editor: Omohodion ...
Fine Needle Aspiration Cytology of Benign Fibrous Histiocytoma of Bone: A Case Report Subject Area: Pathology and Cell Biology ... View articletitled, Fine Needle Aspiration Cytology of Benign Fibrous Histiocytoma of Bone,span class=subtitle-colon,: ,/span ...
Duncan JD, Greenberg SD, Mattox KL, Madewell JE "Benign fibrous histiocytoma: a rare endobronchial neoplasm.." Int Surg.;71(2): ...
Atypical fibrous histiocytoma is an uncommon, poorly documented variant of cutaneous fibrous histioc ... Provided that atypical fibrous histiocytoma is treated by complete excision, a benign outcome is to be expected in most cases. ... Atypical fibrous histiocytoma is an uncommon, poorly documented variant of cutaneous fibrous histiocytoma. We studied 59 cases ... However, similar to the cellular and aneurysmal variants of fibrous histiocytoma, atypical fibrous histiocytoma shows a higher ...
Background: Cutaneous fibrous histiocytoma (CFH) is a common, benign skin tumor predominantly occurring on the extremities or ... A clinicohistopathological analysis of cutaneous fibrous histiocytomas of the finger. Kyung-Hwa Nam, Sang-Woo Park, Seok-Kweon ...
Deep benign fibrous histiocytoma forms in the tissue deep under the skin usually in the legs or head and neck area. It is a ... When a benign fibrous histiocytoma starts in the layers of the skin, it is often called a dermatofibroma. ... A non-cancerous (benign) soft tissue tumour is a growth that does not spread (metastasize) to other parts of the body. Non- ... A leiomyoma that develops in the uterus is also called a fibroid.) These benign tumours may also develop deep in a limb and in ...
... malignant fibrous histiocytoma, localized fibrous tumors, pleural liposarcoma or metastatic renal cell carcinoma. ... Sarcomatoid mesothelioma presents additional difficulties, because the tumors can resemble benign (noncancerous) conditions or ... These tumors also are referred to as sarcomatous, spindled or diffuse malignant fibrous mesothelioma. ... Under a microscope, sarcomatoid tissue samples can appear similar to sarcoma, fibrosarcoma, fibrous pleurisy, ...
Oral benign fibrous histiocytoma: two case reports Fibrous histiocytoma is a benign soft tissue tumour arising as a fibrous ... We report two cases of benign fibrous histiocytoma that l... Authors: Dardo Menditti, Luigi Laino, Antonio Mezzogiorno, Sara ... Benign mesenteric lymphangioma presenting as acute pancreatitis: a case report Benign mesenteric lymphangiomas are rare intra- ... The incidence of soft tissue tumours, both malignant and benign, is very common. However, the coexistence of 4 types of ...
It was first defined as a fibrous xanthoma by Chassaignac in 1952.[5] It is also known as a fibrous histiocytoma of synovium, ... pigmented nodular tenosynovitis, tenosynovial giant cell tumor, localized nodular tenosynovitis, benign synovioma, and fibrous ...
Fibrous hamartoma of infancy is a rare, benign soft tissue tumor that typically occurs within the first two years of life. The ... histiocytoma, dermatofibroma, leiomyosarcoma, and fibrosarcoma.10 ... Fibrous hamartoma of infancy (FHI) is a rare, benign soft ... Fibrous hamartoma of infancy (FHI) is a rare, benign soft tissue tumor that usually occurs within the first two years of life. ... Fibrous hamartoma of infancy. J Pediatr Surg 1988; 23: 759-761.. 8. Greco MA, Schinella RA, Vuletin JC. Fibrous hamartoma of ...
BENIGN FIBROUS HISTIOCYTOMA WITH A RARE LOCATION - A CASE REPORT. Murat Ali HERSEKLİ, Sercan AKPINAR, Fazilet KAYASELÇUK, Metin ...
We present two clinical cases of patients aged 36 and 74 with an orbital solitary fibrous tumour (SFT). The diagnosis was ... Coindre JM (2002) Deep benign fibrous histiocytoma. In World Health Organization classification of tumours. Pathology and ... Solitary fibrous tumour (SFT) is an uncommon neoplasm at the orbital level that behaves in benign way in most cases [1]. It ... with numerous thin-walled vessels with a less fibrous component), a fibrous variant of SFT (with a highly fibrous component) ...
Fusions involving protein kinase C and membrane-associated proteins in benign fibrous histiocytoma. Anna PÅ‚aszczyca, Jenny ...
Histiocytoma, Fibrous. Histiocytoma, Benign Fibrous. Lymphangiomyomatosis. Lymphangioleiomyomatosis. Meigs Syndrome. Meigs ...
Histiocytoma, Fibrous. Histiocytoma, Benign Fibrous. Lymphangiomyomatosis. Lymphangioleiomyomatosis. Meigs Syndrome. Meigs ...
Histiocytoma, Fibrous. Histiocytoma, Benign Fibrous. Lymphangiomyomatosis. Lymphangioleiomyomatosis. Meigs Syndrome. Meigs ...
Histiocytoma, Fibrous. Histiocytoma, Benign Fibrous. Lymphangiomyomatosis. Lymphangioleiomyomatosis. Meigs Syndrome. Meigs ...
Histiocytoma, Fibrous. Histiocytoma, Benign Fibrous. Lymphangiomyomatosis. Lymphangioleiomyomatosis. Meigs Syndrome. Meigs ...
Histiocytoma, Fibrous. Histiocytoma, Benign Fibrous. Lymphangiomyomatosis. Lymphangioleiomyomatosis. Meigs Syndrome. Meigs ...
Histiocytoma, Fibrous. Histiocytoma, Benign Fibrous. Lymphangiomyomatosis. Lymphangioleiomyomatosis. Meigs Syndrome. Meigs ...
Histiocytoma, Fibrous. Histiocytoma, Benign Fibrous. Lymphangiomyomatosis. Lymphangioleiomyomatosis. Meigs Syndrome. Meigs ...
Histiocytoma, Fibrous. Histiocytoma, Benign Fibrous. Lymphangiomyomatosis. Lymphangioleiomyomatosis. Meigs Syndrome. Meigs ...
Histiocytoma, Fibrous. Histiocytoma, Benign Fibrous. Lymphangiomyomatosis. Lymphangioleiomyomatosis. Meigs Syndrome. Meigs ...
Histiocytoma, Fibrous. Histiocytoma, Benign Fibrous. Lymphangiomyomatosis. Lymphangioleiomyomatosis. Meigs Syndrome. Meigs ...
Benign fibrous histiocytoma (morphologic abnormality). Code System Preferred Concept Name. Benign fibrous histiocytoma ( ... Benign fibrous histiocytoma Active Synonym false false 43368019 Fibrous histiocytoma Active Synonym false false ...
  • Benign fibrous histiocytoma is a benign tumor composed of a mixture of fibroblastic and histiocytic cells. (alliedacademies.org)
  • The most important diagnostic distinction is the separation of this tumor from aggressive forms of fibrohistiocytic neoplasms like dermatofibrosarcoma protuberans and malignant fibrous histiocytoma. (alliedacademies.org)
  • Types include: benign fibrous histiocytoma: This tumor has also been termed benign fibrous histiocytomas of the skin, superficial/cutaneous benign fibrous histiocytomas, common fibrous histiocytoma, and more recently dermatofibroma. (wikipedia.org)
  • malignant fibrous histiocytoma: This tumor is now termed undifferentiated pleomorphic sarcoma (UPS) because more recently developed immunohistochemistry and cytogenetic analyses suggest that its neoplastic cells most likely arise from mesenchymal stem cells or fibroblasts rather than histiocytes. (wikipedia.org)
  • This results in the formation of a relatively well-defined zone of compressed fibrous tissue that may contain scattered tumor cells. (medscape.com)
  • Fibrous hamartoma of infancy is a rare, benign soft tissue tumor that typically occurs within the first two years of life. (ispub.com)
  • Immunohistochemical and immunoelectron study of major histocompatibility complex class-II antigen in canine cutaneous histiocytoma: its relation to tumor regression. (illumina.com)
  • On the other hand, clear cell acanthoma is a rare, benign epithelial cutaneous tumor. (medscape.com)
  • This presence of melanin provides pigmentation to the benign tumor, and this occurrence has been termed pigmented clear cell acanthoma. (medscape.com)
  • A small, slowly growing, common benign skin tumor, most often found on the legs. (mylocalclinics.com)
  • A benign, soft tissue tumor occurring mainly in young adults, usually in the limbs and sometimes in the abdomen or throat, which does not metastasize. (mylocalclinics.com)
  • AFX usually has a benign clinical course and complete tumor resection is generally curative. (netlify.app)
  • Is it a benign tumor or a malignant tumor? (cybersight.org)
  • The most common benign bone tumor, typically occurring in the long bones, such as the arms and legs. (healthke.com)
  • A small, benign tumor that often causes pain and tends to affect the long bones. (healthke.com)
  • Giant cell tumor (GCT), also known as pigmented villonodular synovitis, is a rare, slow-growing, and benign neoplasm which arises from the synovium of a joint, tendon sheath, or bursa. (jocr.co.in)
  • A case of late development of a high grade malignant fibrous histiocytoma at the site of a previously surgically treated giant cell tumor is reported. (uthscsa.edu)
  • The patient initially was treated for a benign giant cell tumor of the lateral condyle of the distal femur by curettage, implant of auto- and allograft bone, but no radiation. (uthscsa.edu)
  • After chemotherapy, the tumor was resected and histologically showed no evidence of a recurrent giant cell tumor, only a high grade malignant fibrous histiocytoma. (uthscsa.edu)
  • Non-cutaneous benign FH represents approximately 1% of all benign FH lesions. (alliedacademies.org)
  • The use of "histiocytoma" in these terms refers more to the morphologic appearance of some of the cells that comprise these lesions rather than their lineage: studies to date have not fully determined the lineage of the neoplastic cells in dermatofibroma tumors but recent cell marker studies suggest these cells originate from fibroblasts rather than histiocytes. (wikipedia.org)
  • Generally, soft-tissue tumors grow centripetally, though some benign tumors (eg, fibrous lesions) may grow longitudinally along tissue planes. (medscape.com)
  • Benign lesions were found in 79.9% of cases. (who.int)
  • Under a microscope, sarcomatoid tissue samples can appear similar to sarcoma, fibrosarcoma, fibrous pleurisy, malignant fibrous histiocytoma, localized fibrous tumors, pleural liposarcoma or metastatic renal cell carcinoma. (pleuralmesothelioma.com)
  • Atypical fibrous histiocytoma is an uncommon, poorly documented variant of cutaneous fibrous histiocytoma. (lww.com)
  • Soft tissuefibrohistiocytic tumors - Benign fibrous histiocytoma (superficial). (healthline.com)
  • A histiocytoma is a tumour consisting of histiocytes. (wikipedia.org)
  • A non-cancerous (benign) soft tissue tumour is a growth that does not spread (metastasize) to other parts of the body. (cancer.ca)
  • Fibrous histiocytoma is a benign soft tissue tumour arising as a fibrous mass everywhere in the human body. (biomedcentral.com)
  • We present two clinical cases of patients aged 36 and 74 with an orbital solitary fibrous tumour (SFT). (scitechnol.com)
  • Solitary fibrous tumour (SFT) is an uncommon neoplasm at the orbital level that behaves in benign way in most cases [ 1 ]. (scitechnol.com)
  • The tumour-like growth should be considered a type of skin cancer but it may behave in a benign fashion. (netlify.app)
  • Dermatofibroma(also known as histiocytoma). (healthline.com)
  • When a benign fibrous histiocytoma starts in the layers of the skin, it is often called a dermatofibroma. (cancer.ca)
  • Fibrous histiocytoma/dermatofibroma in children: the same as adults? (cincinnatichildrens.org)
  • Dermatofibromas are benign (noncancerous) and harmless in this regard. (healthline.com)
  • Sarcomatoid mesothelioma presents additional difficulties, because the tumors can resemble benign (noncancerous) conditions or other types of cancer. (pleuralmesothelioma.com)
  • According to an orthopedic specialist , bone tumors can be categorized into two main types: benign (noncancerous) and malignant (cancerous). (healthke.com)
  • Primary bone tumors may be noncancerous (benign) or cancerous (malignant). (msdmanuals.com)
  • Bone tumors may be cancerous (malignant) or noncancerous (benign). (msdmanuals.com)
  • Atypical Fibrous Histiocytoma of the Skin: Clinicopathologic. (lww.com)
  • We studied 59 cases of atypical fibrous histiocytoma to better characterize the clinicopathologic spectrum. (lww.com)
  • We conclude that atypical fibrous histiocytoma has a broader clinicopathologic spectrum than previously realized. (lww.com)
  • Provided that atypical fibrous histiocytoma is treated by complete excision, a benign outcome is to be expected in most cases. (lww.com)
  • However, similar to the cellular and aneurysmal variants of fibrous histiocytoma, atypical fibrous histiocytoma shows a higher tendency to recur locally than ordinary fibrous histiocytoma and may rarely metastasize. (lww.com)
  • atypical squamous cells cannot exclude high grade squamous intraepithelial lesion Fibroxanthoma (M8830/0) - see also Neoplasm, connective tissue, benign. (netlify.app)
  • The ICD-10-CM code D48.5 might also be used to specify conditions or terms atypical fibrous histiocytoma of soft tissue , atypical fibroxanthoma of skin, etc. (netlify.app)
  • International Classification of Diseases (ICD-O-3] 8830/1, Atypical fibrous histiocytoma. (netlify.app)
  • Atypical fibroxanthoma of the skin is a low-grade malignancy related to malignant fibrous histiocytoma, which it resembles histologically. (netlify.app)
  • Reminiscent of benign, malignant, and metastatic neoplasms elsewhere in the body, theses tumors herald their presence by the secondary effects produced while enlarging within the confines of cardiac chambers and tissues. (mhmedical.com)
  • others apply also to benign neoplasms. (netlify.app)
  • Tumors affecting the orbit include benign and malignant neoplasms arising from the various structures in the orbit including the blood vessels, nerves, bones, orbital fat and other soft tissues. (cybersight.org)
  • Fibroxanthoma - see also Neoplasm, connective tissue, benign. (netlify.app)
  • Discussion Orbital SFT is a generally benign neoplasm originating from the mesenchyme, uncommon in the orbit. (scitechnol.com)
  • Giant cell tumors(GCT) are uncommon and benign tumors originating due to proliferation of the tendon synovial sheath. (jocr.co.in)
  • Although most soft-tissue tumors of various histogenetic types are classified as either benign or malignant, many are of an intermediate nature, which typically implies aggressive local behavior with a low-to-moderate propensity for metastasis. (medscape.com)
  • Benign soft-tissue tumors are fairly common and are treated with surgery alone. (medscape.com)
  • Deep benign fibrous histiocytoma forms in the tissue deep under the skin usually in the legs or head and neck area. (cancer.ca)
  • The differential diagnosis includes numerous benign and malignant soft tissue tumors. (ispub.com)
  • Characteristic histologic appearance of fibrous hamartoma of infancy demonstrating an admixture of mature adipose tissue, scattered primitive mesenchymal cells, and dense bundles of fibrous tissue (100x). (ispub.com)
  • A condition in which normal bone is replaced with fibrous tissue, leading to weakened and deformed bones. (healthke.com)
  • The diagnosis of benign fibrous histiocytoma located in the deeper tissues is clinically difficult and is confirmed histopathologically after excision. (alliedacademies.org)
  • Complete surgical excision remains the primary treatment of choice for well-defined, clinically benign orbital tumors. (cybersight.org)
  • Despite its benign nature, the rate of local recurrence after excision has been reported to range between 10%and 20% [7, 8]. (jocr.co.in)
  • Benign fibrous histiocytoma consists of a proliferation of benign histiocytes in addition to inflammatory cells and occasional Reed-Sternberg-like cells. (elsevierpure.com)
  • This article focuses mainly on nonmelanoma skin cancers, with an emphasis on rare benign and malignant epithelial, dermal, and adnexal tumors. (medscape.com)
  • Keloids are benign dermal fibroproliferative tumors with no malignant potential. (acadderm.com)
  • In most benign long bone cartilage tumors there is minimal endosteal scalloping but there should be no cortical expansion nor thickening. (tumorsurgery.org)
  • histiocytoma (dog) "histiocytoma" at Dorland's Medical Dictionary Sbaraglia M, Bellan E, Dei Tos AP (April 2021). (wikipedia.org)
  • Different non-cancerous tumours can develop in fibrous tissues. (cancer.ca)
  • Fibroma is a general term used to describe a group of non-cancerous tumours that start in the skin or fibrous soft tissues, such as tendons and ligaments. (cancer.ca)
  • Both benign and malignant bone tumors require evaluation and individualized treatment strategies by an orthopedic specialist . (healthke.com)
  • These benign tumours may also develop deep in a limb and in the abdominal cavity or the back of the abdomen (retroperitoneum). (cancer.ca)
  • Hidrocystomas are rare, benign, watery or fluid filled cystic proliferations of the skin. (acadderm.com)
  • These benign tumors also tend to be more common in women than men. (healthline.com)
  • One of the most common benign epithelial tumors is seborrheic keratosis /senile keratosis, which is a hereditary lesion that appears in persons aged more than 30 years. (medscape.com)
  • Hodgkin's disease is considered a malignant disorder of the monocyte-histiocyte cell line but also includes benign inflammatory cells as part of its histological picture. (elsevierpure.com)
  • The clinical course is typically benign and prognosis excellent. (ispub.com)
  • After detailed clinical and laboratory examinations, the lesion was excised in toto under general anesthesia, and histopathology revealed it to be a benign fibrous histiocytoma. (alliedacademies.org)
  • Before I go into it, orbital tumors are primarily classified as benign and malignant primary tumors or secondary tumors. (cybersight.org)
  • These tumors also are referred to as sarcomatous, spindled or diffuse malignant fibrous mesothelioma. (pleuralmesothelioma.com)
  • A case of benign fibrous histiocytoma in a patient with previous Hodgkin's disease is reported. (elsevierpure.com)
  • As with all tumors, whether benign or malignant, the paradigm of comprehension depends on identifying the cell or cell layer of origin. (medscape.com)
  • [ 2 ] Tumors are further classified as benign, intermediate, or malignant, and intermediate tumors are designated as either locally aggressive or rarely metastasizing. (medscape.com)